Clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis
Xiangli Ding,1 Qiaochao Chen,2 Zhao Yang,3 Jun Li,4 Hui Zhan,1 Nihong Lu,5 Min Chen,6 Yanlong Yang,7 Jiansong Wang,1 Delin Yang11Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People’s Republic of China; 2Department of Geriatrics, The...
Main Authors: | Ding X, Chen Q, Yang Z, Li J, Zhan H, Lu N, Chen M, Yang Y, Wang J, Yang D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-05-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/clinicopathological-and-prognostic-value-of-pd-l1-in-urothelial-carcin-peer-reviewed-article-CMAR |
Similar Items
-
Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis
by: Jing-Hua Li, et al.
Published: (2018-09-01) -
Prognostic Role of Serum Lactate Dehydrogenase in Patients With Urothelial Carcinoma: A Systematic Review and Meta-Analysis
by: Minhong Wu, et al.
Published: (2020-05-01) -
The prognostic value of De Ritis (AST/ALT) ratio in patients after surgery for urothelial carcinoma: a systematic review and meta-analysis
by: Xu Hu, et al.
Published: (2020-02-01) -
Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder
by: Donghyun Kim, et al.
Published: (2020-04-01) -
Prognostic values of the clinicopathological characteristics and survival outcomes in micropapillary urothelial carcinoma of the bladder: A SEER database analysis
by: Di Jin, et al.
Published: (2020-07-01)